Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2013 Oct 18;142(1):177–185. doi: 10.1007/s10549-013-2729-1

Table 1.

Characteristic of cases and controls

Characteristic Cases n = 128 Controls n = 269 p value
Date of birth (mean) (range) 1965.2 (1947–82) 1964.5 (1946–81) 0.44
Year of diagnosis (range) 1997.3 (1985–2009) 1997.8 (1985–2011) 0.47
Age of breast cancer (range) 32.5 (25–42) 33.8 (26–44) 0.009
Date of baseline questionnaire (range) 2,003.5 (1996–2011) 2,003.7 (1996–2012) 0.84
Mutation n (%)
 BRCA1 106 (81.3 %) 227 (84.4 %) Matched
 BRCA2 24 (18.8 %) 42 (15.6 %)
Place of residence 96 (75.0 %) 210 (78.1 %) Matched
 North America 20 (15.6 %) 43 (16.0 %)
 Poland 12 (9.4 %) 16 (6.0 %)
 Others
Parous
 No 0 78 (29.5 %) 0.62
 Yes 128 (100 %) 191 (71.0 %)
 Mean Parity 2.1(1–5) 2.0 (1–4)
Age of menarche (years) 12.8 (9–17) 12.8 (10–21) 0.73
Age at first birth (years) 30.7 (18–42) 25.6 (18–33) < 0.0001
Age at last birth (years) 35.0 (27–44) 28.7 (20–38) < 0.0001
Time from diagnosis to last childbirth (years) 2.4 (0–13) NA < 0.0001
Salpingo-oophorectomy after breast cancer diagnosis
 No 55 (43.0 %) 127 (47.2 %)
 Yes 73 (57.0 %) 142 (52.8 %) 0.43
Vital status
 Alive 120 (92.8 %) 246 (91.5 %)
 Dead 8 (6.3 %) 23 (8.6 %) 0.42
Cause of death
 Breast cancer 7 19
 Unknown 1 4